GlassScriptPhysician profile
Joseph A Girgis
NPI 1972571503
$5,383.65
in general payments reported to CMS, 2019-2025
40 companies · $796 in 2025
The $796 reported for 2025 was more than what 81% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $774 · 2021: $1,177 · 2022: $845 · 2023: $808 · 2024: $759 · 2025: $796.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,351 · Education: $12.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,350.96 |
| Education | $12.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $954.35 | 2019-2025 | |
| Glaxosmithkline, LLC. | $535.58 | 2020-2025 | Trelegy Ellipta |
| Novo Nordisk INC | $417.55 | 2020-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $360.53 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Allergan, INC. | $277.56 | 2019-2020 | |
| Gilead Sciences, INC. | $250.25 | 2019-2025 | |
| Lilly USA, LLC | $221.85 | 2020-2025 | Mounjaro, Zepbound |
| Esperion Therapeutics, INC. | $221.34 | 2021-2025 | Nexletol |
| Apyx Medical Corporation | $212.98 | 2020 | |
| Antares Pharma, INC. | $208.07 | 2022-2024 | Xyosted, Nocdurna, Tlando |
| Pfizer INC. | $201.93 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $173.02 | 2022-2024 | |
| Dexcom, INC. | $172.08 | 2021-2024 | Dexcom G6 Transmitter |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $164.91 | 2022-2025 | Caplyta |
| Amgen INC. | $144.23 | 2022-2025 | Repatha, Otezla, Otezla |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $120.85 | 2024 | Apretude |
| Kowa Pharmaceuticals America, INC. | $99.00 | 2019-2025 | Zoryve |
| Verity Pharmaceuticals INC. | $69.17 | 2024-2025 | Tlando |
| Amarin Pharma, INC. | $68.10 | 2021-2022 | |
| Horizon Therapeutics Plc | $51.52 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $40.85 | 2020-2021 | |
| Exact Sciences Corporation | $38.17 | 2025 | Cologuard Collection Kit |
| Jazz Pharmaceuticals INC. | $35.02 | 2020-2021 | |
| Tolmar, INC. | $31.90 | 2023-2024 | |
| Lundbeck LLC | $30.71 | 2024 | Rexulti |
| Acella Pharmaceuticals, LLC | $29.51 | 2024-2025 | NP Thyroid 60 |
| Halozyme INC | $25.35 | 2023 | |
| Phathom Pharmaceuticals, INC. | $22.50 | 2025 | Voquezna |
| Dermira, INC. | $21.36 | 2020 | |
| Cmp Pharma, INC. | $20.61 | 2022 | |
| Axsome Therapeutics, INC. | $20.00 | 2024 | Auvelity |
| Ibsa Pharma INC. | $20.00 | 2023 | Tirosint, Licart |
| Clarus Therapeutics INC. | $18.46 | 2021 | |
| Acerus Pharmaceuticals Corporation | $18.08 | 2021 | |
| Abbott Laboratories | $16.19 | 2022 | |
| Insulet Corporation | $15.69 | 2022 | |
| Janssen Pharmaceuticals, INC | $15.41 | 2019 | |
| Bausch Health US, LLC | $15.30 | 2022 | |
| Lucid Diagnostics INC. | $15.00 | 2022 | |
| Cashflow Solutions, LLC | $8.67 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Girgis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.